Jasper Therapeutics Inc (JSPR)
Healthcare
Biotechnology
0.63 $
+1.5%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns Jasper Therapeutics Inc (JSPR)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 78.4% of the shares are freely tradable; institutional investors hold 60.5%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
60.5%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
1.2%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
78.4%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
7.2%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
28Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Velan Capital Investment Management LP | 9.53 | 2,668,395 | +0.0 | 03/31/2026 |
| Millennium Management LLC | 5.78 | 1,617,531 | +50.6 | 03/31/2026 |
| Kingdon Capital Management LLC | 4.83 | 1,352,106 | +0.0 | 03/31/2026 |
| Morgan Stanley - Brokerage Accounts | 4.76 | 1,333,420 | -32.3 | 03/31/2026 |
| Vanguard Group Inc | 4.74 | 1,326,512 | +28.4 | 12/31/2025 |
| Vanguard Capital Management, LLC | 4.19 | 1,172,597 | +0.0 | 03/31/2026 |
| Rock Springs Capital Management LP | 3.93 | 1,100,726 | +0.0 | 03/31/2026 |
| The Carlyle Group Inc | 3.81 | 1,066,189 | +0.0 | 03/31/2026 |
| BOOTHBAY FUND MANAGEMENT, LLC | 2.08 | 582,751 | -26.6 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 2.98 | 833,391 | +0.0 | 04/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.